OTR overexpression-induced metastasis might thus be associated with EGF in the tumour microenvironment, which was investigated by replacing 10% FBS with EGF (20 ng/mL) as the chemoattractant in the transwell migration assay. The gene discussed is EGF; the disease is neoplasm.